Dierks follows Walz as NuPharm’s chief
NuPharm has appointed former Meda chief executive officer (CEO) Jörg-Thomas Dierks to become CEO of the European central nervous system (CNS) specialist, replacing with immediate effect Stephan Walz, who has “decided to step down in order to pursue other activities”.
You may also be interested in...
Neuraxpharm has appointed Craig Bowen as general manager of its UK affiliate at the same time as the European central nervous system specialist has launched its first products in the UK market.
The decision by IQWiG could have an impact on how Palforzia is priced if the findings are upheld.
Lupin is hoping that a newly-struck partnership with women’s health specialist Exeltis will improve the fortunes of its Solosec (secnidazole) bacterial vaginosis and trichomoniasis treatment in the US.